期刊文献+

美国openFDA数据公开对我国食品药品监管数据管理的启示 被引量:12

On OpenFDA and Enlightenments for Data Management of Food and Drug Administration in China
下载PDF
导出
摘要 目的:分析美国食品药品管理局(FDA)公共数据开放项目(openFDA)的启动背景、运行模式和管理经验,为我国食品药品监管数据管理工作提供参考。方法:采用文献研究的方法,对FDA政府网站有关专栏和openFDA项目网站以及在中国知网等数据库中检索到的文献资料进行分析研究。结果与结论:openFDA项目自开展以来积累了大量数据,采取提供应用程序接口、提供数据资料直接下载,以及建立开发者社区为其提供交流和分享的平台多种方式进行公共数据开放,并已取得了一定成效,值得思考借鉴。 Objective: To analyze the background, mode and management experience of openFDA, in order to provide references for the data management of food and drug administration in China. Methods: Relevant columns on FDA websites, openFDA project website, literatures found in the China National Knowledge Internet(CNKI) and other databases were analyzed using the method of literature analysis. Results and Conclusion: The open FDA project has accumulated a lot of data since its implementation and has provided several to improve the data opening of openFDA, including providing application interface, direct data download as well as establishing, a developer community to provide communication and sharing platform, and has been proved effective in practice, which is enlightenments for us.
作者 宗欣 王迎利
出处 《中国药事》 CAS 2017年第9期976-979,共4页 Chinese Pharmaceutical Affairs
关键词 大数据 食品药品监管 数据管理 数据公开 big data food and drug administration data management data opening
  • 相关文献

参考文献2

二级参考文献17

  • 1FDA. OpenFDA: Innovative initiative opens door to wealth of FDA's publicly available data[EB/OL].(2014-06-02)[2015-06-18].https:// open.fda.gov/update/openfda-innovative-initiative-opens-door- to-wealth-of-fda-publicly-available-data/. 被引量:1
  • 2FDA. Providing easy access to medical device reports submitted to FDA since the early 1990s [EB/OL].(2014-08-19) [2015-06-18] https://open.fda. gov/update/providing-easy-access-to-medica3-device-reports/. 被引量:1
  • 3FDAFDAAdverseEvent Reporting System (FAERS)[EB/OL].(2014- 09-08)[2015-06-18]http://www.fda.gov /Drugs/GuidanceComp- lianceRegulatoryInformation/Surveillance/AdverseDrugEffects/. 被引量:1
  • 4FDA.Getting started with openFDA [EB/OL]. (2015-06-18) [2015-06-18].https://open.fda.gov/api/reference/. 被引量:1
  • 5ECMA Intemational.介绍 JSON[EB/OL].(2015-06-18)[2015-06- 18].http://j son.org/j son-zh.html. 被引量:1
  • 6The R Foundation.The R Project for Statistical Computing [EB/OL]. (2015-06-18)[2015-06-18].http://www.r-project.org/. 被引量:1
  • 7Jeroen O, Duncan L, Lloyd H.Getting started with JSON and json- lite[EB/OL].(2015-06-18)[2015-06-18].http://cran.r-project.org/ web/packages/jsonlite/vignettes/json-aaquickstart.html. 被引量:1
  • 8FDA. FDA Drug Safety Communication: Safety Review of possi- ble increased risk of blood clots with birth control pills containing drospirenone[EB/OL].(2011-05-31)[2015-06-18].http://www.fda. gov/Drugs/DrugSafety/ucm257164.htm. 被引量:1
  • 9FDA. FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone [EB/OL]. (2011-09-26) [2015-06-18]. http://www.fda.gov/Drugs/DrugSafety/ucm273021.htm. 被引量:1
  • 10FDA. label approved on 06/01/2015 for YASMIN, NDA no. 021098 [EB/OL]. (2015-06-01) [2015-06-18].http://www.accessdata.fda. gov / drugsatfda_docs/label/2015/021098s0231bl.pdf. 被引量:1

共引文献45

同被引文献85

引证文献12

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部